Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Toronto
Clinical trial register · Canada

Clinical Trials in Toronto, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Canada and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6567 matching records held by the registry are in this view. Synced 17 Nov 2026, 03:20 UTC
6567
Studies in scope
all four open statuses
3485
Recruiting now
open to new participants
883
Lead sponsors
across recruiting studies
Top sites
Toronto 10 Edmonton 6 Calgary 5 Ottawa 3 Vancouver 3
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Trials with a site in Toronto

10 of 6567 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Canada
Start
Recruiting
GlaxoSmithKline
Phase 2
80
Calgary, Toronto
2025-06-05
Recruiting
Takeda
Phase 3
225
Edmonton, Vancouver, Halifax, London, Toronto
2025-05-06
Recruiting
OURA Ring Wearable Testing in MDS Patients: a Feasibility and Discovery Pilot Study
NCT06270771MDS, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, RARS-T
Sunnybrook Health Sciences Centre
Observational
60
Toronto
2025-03-20
Active, closed
Bristol-Myers Squibb
Phase 3
402
Calgary, Vancouver, London, Toronto
2023-10-24
Active, closed
A Study of CFI-400945 With or Without Azacitidine in Patients With AML, MDS or CMML
NCT04730258Acute Myeloid Leukemia, Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, AML
Treadwell Therapeutics, Inc
Phase 1/2
72
Edmonton, Toronto
2021-04-16
Recruiting
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
NCT04256317Myelodysplastic Syndromes, Acute Myeloid Leukemia, Myelodysplastic Syndrome/Neoplasm, Chronic Myelomonocytic Leukemia
Taiho Oncology, Inc.
Phase 2/3
316
St. John's, Toronto
2020-05-21
By invitation
A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
NCT04093570Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndromes
Taiho Oncology, Inc.
Phase 2
332
Edmonton, Nova Scotia, Ottawa, Toronto
2019-09-30
Active, closed
Geron Corporation
Phase 2/3
289
Calgary, Edmonton, Ottawa, Toronto, Montreal
2016-01-12
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Canadian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 17 November 2026. https://priyalifescience.com/clinical-trials-canada/city/toronto

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Canada and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,567 studies in total at the last sync on 17 Nov 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies with a site in Toronto that also match the filters currently applied.

How many clinical trials are recruiting in Toronto?

4 of the 10 studies on this page are recruiting new participants as of the 17 Nov 2026, 03:20 UTC sync. A further 0 have not yet opened recruitment, 5 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Toronto), 10 studies
PhaseStudiesRecruitingShare
Phase 2/33130%
Phase 33130%
Phase 22120%
Observational1110%
Phase 1/21010%

Most active sponsors

Lead sponsors with the most studies (Toronto)
Lead sponsorStudiesRecruiting
Bristol-Myers Squibb20
Taiho Oncology, Inc.21
Celgene10
Geron Corporation10
GlaxoSmithKline11
Sunnybrook Health Sciences Centre11
Takeda11
Treadwell Therapeutics, Inc10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.